[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"meralgia-paresthetica\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:meralgia-paresthetica":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100618761","the-effectiveness-of-low-level-laser-therapy-in-the-treatment-of-meralgia-paresthetica-100618761",false,"NCT07335822","The Effectiveness of Low-Level Laser Therapy in the Treatment of Meralgia Paresthetica","Inclusion Criteria: Patients aged 18 to 70 with neuropathic complaints in the anterolateral thigh, whose diagnosis has been confirmed by sensory conduction studies of the lateral femoral cutaneous nerve.\n\nExclusion Criteria: - Patients with diabetes mellitus\n\n* Patients with polyneuropathy\n* Patients with radicular pain\n* Patients receiving treatment for neuropathic pain\n* Patients who have received an injection to the lateral femoral cutaneous nerve within the last three months\n* Patients who have undergone physical therapy modalities for a diagnosis of meralgia paresthetica within the last three months\n* Patients with a history of pelvic surgery\n* Patients diagnosed with rheumatologic diseases\n* Pregnant women\n* Patients with active skin infections\n* Malignancy\n* Fibromyalgia","ALL","18 Years","70 Years",{"count":19,"type":20},44,"ESTIMATED","INTERVENTIONAL",[23],"NA","Patients diagnosed with meralgia paresthetica via electromyography (EMG), who present with neuropathic complaints on the lateral thigh to the Physical Medicine and Rehabilitation outpatient clinics of our hospital, will be included in the study after reviewing exclusion criteria. Patients will be randomized into two equal groups using a sealed-envelope system. The treatment group will receive low-level laser therapy (LLLT) combined with simultaneous transcutaneous electrical nerve stimulation (TENS), while the control group will receive placebo laser therapy combined with simultaneous TENS.\n\nAn LED gallium-aluminum-arsenide (Ga-Al-As) diode laser device with a power of 1.6 W and a wavelength of 808 nm will be used in the study. The treatment will consist of 10 sessions, applied over two weeks, five days per week.\n\nDemographic data (age, gender, body mass index, and occupation) of all patients included in the study will be recorded. Pain and functional impairment will be evaluated using the VAS, SF-36, PSQI, and S-LANSS scales for all patients. VAS, SF-36, PSQI, and S-LANSS scores will be assessed at the end of the treatment and on the 30th day after treatment completion (6th-week after baseline). The effectiveness of low-level laser therapy will be investigated using statistical data analysis methods.\n\nLow-level laser therapy will be applied perpendicularly, consistent with the lateral femoral cutaneous nerve projection, delivering a total of 4 J of energy over 12 minutes. TENS electrodes will be placed on the painful anterolateral thigh region in both groups. The stimulation pulse frequency will be set to 100 Hz, and the pulse width will be set to 100 ms. In the control group, sham laser will be applied using the same device and in the same manner; however, no laser beam will be emitted to the designated areas.",[26,27],"Meralgia Paresthetica","Lateral Femoral Cutaneous Nerve Entrapment",[26,29,30,31,32],"Lateral Femoral Cutaneous Nerve","Entrapment neuropathy","Low-Level Laser Therapy","thigh pain","RECRUITING","2026-03-04",{"date":36,"type":37},"2026-03-05","ACTUAL",{"date":39,"type":20},"2026-03-02",{"date":41,"type":20},"2026-06-05",{"name":43,"class":44},"Istanbul Training and Research Hospital","OTHER_GOV",{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":55,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":67,"leadSponsor":69,"locationsCount":72},"100618187","the-efficacy-of-high-power-laser-therapy-in-meralgia-paresthetica-100618187","NCT07328360","The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica","The Efficacy of High-Power Laser Therapy as an Adjunct to Conservative Management in Patients With Meralgia Paresthetica: A Randomized, Assessor-Blinded, Controlled Trial","Inclusion Criteria:\n\n* Adults aged 18-65 years.\n* Clinical diagnosis of MP (based on history: burning pain, tingling, numbness in the lateral thigh; tenderness over the inguinal ligament near the anterior superior iliac spine (ASIS); and a positive pelvic compression test or Tinel's sign over the lateral femoral cutaneous nerve (LFCN)).\n* Symptoms persistent for at least 3 months (chronic).\n* A baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).\n\nExclusion Criteria:\n\n* Secondary MP (e.g., due to pelvic surgery, trauma, or tumor mass effect confirmed by imaging).\n* Significant lumbar radiculopathy (L1-L2).\n* Coagulopathy, use of anticoagulants.\n* Pregnancy.\n* Skin disease or infection in the treatment area.\n* Presence of a cardiac pacemaker.\n* Severe cognitive impairment.","65 Years",{"count":54,"type":20},50,[23],"The management of MP typically follows a conservative pathway, encompassing patient education, lifestyle modifications (e.g., avoidance of tight garments, weight loss), pharmacotherapy (such as neuropathic pain agents or corticosteroid injections), and physical therapy. However, evidence supporting the efficacy of these interventions is largely anecdotal or derived from low-quality studies, and a substantial proportion of patients experience persistent symptoms refractory to standard care.\n\nTherefore, the primary objective of this randomized, sham-controlled, assessor-blinded study is to investigate the efficacy of HPLT as an adjunct to standard conservative care on pain intensity, sensory symptoms, and functional capacity in patients with chronic Meralgia Paresthetica. The investigators hypothesize that patients receiving active HPLT will demonstrate significantly greater improvements in these outcomes compared to those receiving a sham laser procedure",[26],[59,26,60,61,62],"Laser Therapy","Pain","Itching","discopathy","2026-01-12",{"date":65,"type":37},"2026-01-13",{"date":63,"type":37},{"date":68,"type":20},"2026-08-05",{"name":70,"class":71},"Uşak University","OTHER",1]